Managing Cost Maximising Value

We help clients to obtain full value for  their cash without compromising on product quality.

Under the current economic climate keeping the drug development cost down is vital. This need is even more acute in start-up and emerging companies where the revenue streams are limited. The natural tendency for achieving this imperative is to negotiate harder with the suppliers and contactors or to use low-cost providers. Invariably, this method of reducing ‘cost’ leads to a reduction in ‘value’.

We apply our expertise in early economic evaluation (E³ modelling) and value engineering to help you devise and implement effective strategies to reduce your drug development and manufacturing costs including:

• Cost of goods (CoGS) projections
• Drug substance manufacturing cost estimates
• Insight into labour, facility and raw material cost contribution
• Cost-benefit analysis of changing synthetic route or process
• Identifying cost saving opportunities
• Enhancing product value for out-licensing
• Reducing investment risk